Logos Global Management »

Nextcure shares owned by Logos Global Management

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.0M 2.5M 1.59
2024-03-31 $4.3M 1.9M 2.23

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Nextcure

Sofinnova Ventures
Logos Global Management
Affinity Asset Advisors
OrbiMed Advisors
Vanguard Group
BlackRock
BlackRock
Tang Capital Management
Cable Car Capital
Long Focus Capital Management
Acadian Asset Management
Renaissance Technologies
Acuitas Investments
Federated Investors
BML Capital Management

View all funds holding Nextcure